Research Diagnosis Related Groups (DRG) level ICU LOS quality outcomes for Good Samaritan Hospital Medical Center located at 1000 Montauk Hwy, West Islip, NY, 11795 & includes data from NPIs 1902865355
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark ICU length of stay (LOS) outcomes for Good Samaritan Hospital Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,006 | 1,878 | ||||||||||
| Surgical | 496 | 475 | ||||||||||
| Non Surgical | 1,510 | 1,403 | ||||||||||
| Cardiovascular | 405 | 387 | ||||||||||
| General Medicine | 389 | 347 | ||||||||||
| Pulmonology | 256 | 247 | ||||||||||
| Gastroenterology & Endocrinology | 210 | 200 | ||||||||||
| Orthopedics | 167 | 164 | ||||||||||
| Urology | 160 | 155 | ||||||||||
| General Surgery | 158 | 143 | ||||||||||
| Neurology | 121 | 104 | ||||||||||
| Oncology & Hematology | 70 | 67 | ||||||||||
| Psychiatry & Mental Disorders | 17 | 13 | ||||||||||
| Colorectal | 14 | 13 | ||||||||||
| Spine | 13 | 13 | ||||||||||
| Obstetrics & Gynecology | 11 | 11 |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Endovascular Procedures |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cholecystectomy | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| Kidney And Ureter Procedures |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Extracranial Procedures | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| Seizures |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. ICU LOS | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. ICU LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. ICU LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |